Association of immunohistochemical markers of tumor subtype with response to neoadjuvant chemotherapy and survival in patients with muscle-invasive bladder cancer

PURPOSE: A readily accessible biomarker to identify which patients with bladder cancer are more likely to respond to neoadjuvant chemotherapy (NAC) could help clinicians avoid unnecessary chemotherapy and prevent its subsequent complications in some patients. The primary objective of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Razzaghdoust, Abolfazl, Ghajari, Mahdi, Basiri, Abbas, Torbati, Peyman Mohammadi, Jafari, Anya, Fattahi, Mohammad-Reza, Salahi, Maryam, Mofid, Bahram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100015/
https://www.ncbi.nlm.nih.gov/pubmed/33943049
http://dx.doi.org/10.4111/icu.20200425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100015/
https://www.ncbi.nlm.nih.gov/pubmed/33943049
http://dx.doi.org/10.4111/icu.20200425

Ejemplares similares